Forecast: Renin-Angiotensin System Medicine Sales in Germany

The sales of Renin-Angiotensin System medications in Germany are projected to gradually decline from 2024 to 2026, with stabilization observed from 2026 to 2028. The forecast highlights a diminishing trend starting from 3.4% in 2024 to 3.2% in 2026 through 2028, indicating a consolidating market. As of 2023, this segment’s value represented a slightly higher percentage, from which a successive yearly decrease is apparent, capturing a gradual contraction.

To watch for in future trends:

• Development of generic alternatives influencing market dynamics.
• Potential impacts from technological healthcare advancements.
• Regulatory changes affecting market access and reimbursement pathways.